Recent PHAT Stock Price | PHAT Stock Predictions | |
$8.71 | +171.76% |
$23.67 |
Recent PHAT Analyst Ratings Breakdown, Making PHAT Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 5 | 5 | 5 | 5 |
Buy ratings: | 1 | 1 | 1 | 1 |
Hold ratings: | 1 | 1 | 1 | 1 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 1.43 | 1.43 | 1.43 | 1.43 |
For the PHAT stock predictions from the analysts covering Phathom Pharmaceuticals Inc, we have collected all of the individual PHAT stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 6 different analysts covering PHAT (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since PHAT stock predictions may vary widely, another useful metric to consider is the median PHAT stock prediction, which represents the price at which half of the analysts
made PHAT stock predictions that were higher and half made PHAT stock predictions that were lower. This makes for a different take on the PHAT stock predictions out there, as compared to average or mean.
And that median across all the individual PHAT stock predictions was: $27.0 as of 2024-12-03.
The very highest of the PHAT stock predictions for one year price target was $28.0, while the very lowest of the PHAT stock predictions in the analyst group was
$12.0 (with a standard deviation of $6.501). Get the latest Zacks research report on PHAT — FREE
Find out: PHAT next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
MAXN Stock Predictions
OPRA Stock Predictions
NBR Stock Predictions
SSD Stock Predictions
ASPN Stock Predictions
GIS Stock Predictions
SLAB Stock Predictions
CLPR Stock Predictions
AVD Stock Predictions
|
|
Strong Buy (3.57 out of 4) 65th percentile
(ranked higher than approx. 65% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |